Is a Chlamydia Vaccine on the Horizon?

All of the women who received the vaccine produced antibodies to chlamydia, but one of the vaccines, called CTH522:CAF01, produced nearly six times more antibodies than the other vaccine, the investigators found.
Source: WebMD Health - Category: Consumer Health News Source Type: news

Related Links:

Publication date: 17 August 2019Source: New Scientist, Volume 243, Issue 3243Author(s): Jessica Hamzelou
Source: New Scientist - Category: Science Source Type: research
Three medical stories from the week that we didn't cover, explained.Medscape
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Family Medicine/Primary Care Article Source Type: news
The first ever chlamydia vaccine to reach the clinical trial stage has passed initial safety tests, reveals a new study published this week.
Source: Nursing Times - Category: Nursing Source Type: news
A potential vaccine for chlamydia, which infects millions each year, has passed an important early test on the road to availability.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
A potential vaccine for our most common sexually transmitted infection has passed an important early test on the road to availability.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
Source: Fertility News - Doctors Lounge - Category: Reproduction Medicine Tags: Infections, Reproductive Medicine, Research, News, Source Type: news
The first-ever human trial of a genital-chlamydia vaccine suggests that it is safe and effective, according to a new study published in the Lancet. U.S. sexually transmitted illness diagnoses have reached new highs for the past four years in a row, and chlamydia is responsible for the bulk of those infections: 1.7 million cases were diagnosed in 2017 alone, according to the U.S. Centers for Disease Control and Prevention, compared to about 550,000 cases of gonorrhea, 40,000 cases of HIV and 30,000 cases of syphilis. Globally, the problem is even more widespread: about 127 million cases were diagnosed in 2016, according to ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized embargoed study Research Source Type: news
Scientists from the Statens Serum Institut in Copenhagen tested two injections on 35 healthy female volunteers. After five months, none of the women had suffered any serious side effects.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
The first human trial of a jab to tackle the sexually transmitted disease shows promise, say experts.
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
Pioneering clinical trial raises hopes of cure for ‘hidden’ sexually transmitted infectionA vaccine to protect against chlamydia has moved closer to becoming reality after a pioneering clinical trial found the treatment to be safe.The vaccine successfully provoked an immune response, boosting levels of antibodies against the chlamydia bacterium in the blood and vaginal fluids.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Chlamydia Sexual health Society Infectious diseases Medical research Microbiology Science Source Type: news
More News: Chlamydia | Health | Vaccines | Women